Inquiry Basket

Fluorescein | CAS 2321-07-5
Catalog Number | F04-0037 |
Category | Fluorescein FAM |
Molecular Formula | C20H12O5 |
Molecular Weight | 332.31 |
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
Fluorescein is a synthetic fluorescent tracer, used in ophthalmology as a tool in the diagnosis of corneal abrasions, corneal ulcers and herpetic corneal infections.
Chemical Information
Product Specification
Computed Properties
Literatures
Patents
Related CAS | 518-47-8 (disodium salt) |
Synonyms | 3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one; C.I. 45350; Colircusi Fluoresceina; D and C Yellow No. 7; D and C Yellow No. 8; Diofluor; Dipotassium Salt, Fluorescein; Disodium Fluorescein; Disodium Salt, Fluorescein; Fluor I Strip A.T.; Fluor-I-Strip A.T.; Fluorescéine sodique Faure; Fluorescein; Fluorescein Dipotassium Salt; Fluorescein Disodium Salt; Fluorescein Monosodium Salt; Fluorescein Sodium; Fluorescein Sodium, Minims; Fluorescein, Disodium; Fluorescein, Sodium; Fluoresceina, Colircusi; Fluoresceine, Minims; Fluorescite; Fluorets; Ful Glo; Ful-Glo; Funduscein; Minims Fluorescein Sodium; Minims Fluoresceine; Minims Stains; Monosodium Salt, Fluorescein; Optifluor Diba; Sodium Fluorescein; Sodium, Fluorescein; Uranine |
Purity | ≥90% |
IUPAC Name | 3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one |
Canonical SMILES | C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O |
InChI | 1S/C20H12O5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22H |
InChIKey | GNBHRKFJIUUOQI-UHFFFAOYSA-N |
Solubility | Soluble in DMSO (Slightly), Methanol (Slightly) |
Density | 1.60±0.1 g/cm3 |
Appearance | Brown to Dark Red Solid |
Refractive Index | 1.46355 |
Boiling Point | 620.8±55.0 °C at 760 Torr |
MDL Number | MFCD00005050 |
Vapor Pressure | 4.1X10-14 mm Hg at 25 °C (est) |
LogP | 3.4 |
Maximum Absorption Wavelength | 490(0.1mol/L NaOH sol.) nm |
Storage | Cool and dry place, sealed. |
Signal | Warning |
GHSHazardStatements | H302 (13.82%): Harmful if swallowed [Warning Acute toxicity, oral] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] |
Precautionary Statement Codes | P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501 (The corresponding statement to each P-code can be found at the GHS Classification page.) |
XLogP3 | 3.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | 332.06847348 g/mol |
Monoisotopic Mass | 332.06847348 g/mol |
Topological Polar Surface Area | 76Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 522 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PMID | Publication Date | Title | Journal |
---|---|---|---|
36870414 | 2023-04-01 | Comparison of adjuvant mechanisms of medium-chain triacylglycerol in a mouse FITC-induced contact hypersensitivity model | Toxicology |
28551711 | 2017-12-01 | Why are most phospholipidosis inducers also hERG blockers? | Archives of toxicology |
28887287 | 2017-12-01 | Characterization of simvastatin acid uptake by organic anion transporting polypeptide 3A1 (OATP3A1) and influence of drug-drug interaction | Toxicology in vitro : an international journal published in association with BIBRA |
28729014 | 2017-11-01 | Evaluating ureteral patency in the post-indigo carmine era: a randomized controlled trial | American journal of obstetrics and gynecology |
27989701 | 2017-04-01 | Inhibition of SLC drug transporter activities by environmental bisphenols | Toxicology in vitro : an international journal published in association with BIBRA |
Publication Number | Title | Priority Date |
---|---|---|
WO-2022078524-A2 | Specific conjugation of an antibody | 2021-11-03 |
WO-2022078524-A4 | Specific conjugation of an antibody | 2021-11-03 |
US-11331322-B1 | Medicament for preventing and/or treating dry eye | 2021-09-15 |
US-11535900-B1 | Methods and systems for analysis of samples containing particles used for gene delivery | 2021-09-03 |
US-2022411856-A1 | Compact optical high-speed system for nucleic acid amplification and detection | 2021-06-29 |
Recommended Services
Recommended Articles

- Hoechst Dyes: Definition, Structure, Mechanism and Applications
- Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
- Fluorescent Probes: Definition, Structure, Types and Application
- Fluorescent Dyes: Definition, Mechanism, Types and Application
- Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
- BODIPY Dyes: Definition, Structure, Synthesis and Uses
- Cyanine Dyes: Definition, Structure, Types and Uses
- Fluorescein Dyes: Definition, Structure, Synthesis and Uses
- Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
- Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
- Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
- Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
- Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
- DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
- Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
- Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
- Fluorescent Labeling: Definition, Principles, Types and Applications
Recommended Products
Online Inquiry